

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.18885253 |
| 2 | actin-myosin filament sliding (GO:0033275) | 6.68212994 |
| 3 | muscle filament sliding (GO:0030049) | 6.68212994 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 6.09487772 |
| 5 | actin-mediated cell contraction (GO:0070252) | 5.58272513 |
| 6 | skeletal muscle contraction (GO:0003009) | 5.48720325 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.81493600 |
| 8 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.56516952 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.55252968 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.50685055 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.50364799 |
| 12 | negative regulation of protein localization to cell surface (GO:2000009) | 4.48138413 |
| 13 | vocalization behavior (GO:0071625) | 4.47914760 |
| 14 | negative regulation of heart rate (GO:0010459) | 4.46664126 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.40151678 |
| 16 | glutamate secretion (GO:0014047) | 4.34427461 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.32933140 |
| 18 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.28246008 |
| 19 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.28246008 |
| 20 | protein localization to synapse (GO:0035418) | 4.22285700 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.21502568 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.20997168 |
| 23 | sperm motility (GO:0030317) | 4.13063651 |
| 24 | acrosome reaction (GO:0007340) | 4.11779552 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.09071397 |
| 26 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.08246977 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.07512523 |
| 28 | negative regulation of norepinephrine secretion (GO:0010700) | 4.06912859 |
| 29 | myotube cell development (GO:0014904) | 4.03973043 |
| 30 | striated muscle contraction (GO:0006941) | 4.03920754 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.02866685 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 4.02223908 |
| 33 | calcium ion-dependent exocytosis (GO:0017156) | 4.00086298 |
| 34 | skeletal muscle tissue regeneration (GO:0043403) | 3.95010024 |
| 35 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.93114258 |
| 36 | skeletal muscle fiber development (GO:0048741) | 3.92262960 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 3.87591135 |
| 38 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.85836887 |
| 39 | creatine metabolic process (GO:0006600) | 3.84083979 |
| 40 | adenosine receptor signaling pathway (GO:0001973) | 3.82656814 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.82273750 |
| 42 | epithelial cilium movement (GO:0003351) | 3.81303364 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.77930208 |
| 44 | behavioral response to nicotine (GO:0035095) | 3.77912169 |
| 45 | actin filament-based movement (GO:0030048) | 3.77814561 |
| 46 | myofibril assembly (GO:0030239) | 3.70332697 |
| 47 | synaptic vesicle maturation (GO:0016188) | 3.69630815 |
| 48 | relaxation of muscle (GO:0090075) | 3.69574056 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.68520731 |
| 50 | membrane depolarization during action potential (GO:0086010) | 3.67678230 |
| 51 | presynaptic membrane assembly (GO:0097105) | 3.65245770 |
| 52 | axonemal dynein complex assembly (GO:0070286) | 3.62127775 |
| 53 | acrosome assembly (GO:0001675) | 3.59959706 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.58016727 |
| 55 | polyamine biosynthetic process (GO:0006596) | 3.54941703 |
| 56 | neurotransmitter secretion (GO:0007269) | 3.53197110 |
| 57 | sarcomere organization (GO:0045214) | 3.52290884 |
| 58 | glycogen catabolic process (GO:0005980) | 3.51108624 |
| 59 | regulation of cilium movement (GO:0003352) | 3.50274632 |
| 60 | negative regulation of muscle contraction (GO:0045932) | 3.50063555 |
| 61 | presynaptic membrane organization (GO:0097090) | 3.49877941 |
| 62 | motile cilium assembly (GO:0044458) | 3.49403571 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48964826 |
| 64 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48390281 |
| 65 | response to histamine (GO:0034776) | 3.47863362 |
| 66 | cilium movement (GO:0003341) | 3.47219195 |
| 67 | negative regulation of appetite (GO:0032099) | 3.46976527 |
| 68 | negative regulation of response to food (GO:0032096) | 3.46976527 |
| 69 | NADH dehydrogenase complex assembly (GO:0010257) | 3.46118157 |
| 70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.46118157 |
| 71 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.46118157 |
| 72 | locomotory exploration behavior (GO:0035641) | 3.40216063 |
| 73 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.38368601 |
| 74 | thrombin receptor signaling pathway (GO:0070493) | 3.36695329 |
| 75 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.35439077 |
| 76 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.35016647 |
| 77 | regulation of platelet aggregation (GO:0090330) | 3.34301947 |
| 78 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.33552751 |
| 79 | regulation of cell communication by electrical coupling (GO:0010649) | 3.33491554 |
| 80 | regulation of female receptivity (GO:0045924) | 3.30788284 |
| 81 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.30787056 |
| 82 | glutamate receptor signaling pathway (GO:0007215) | 3.30545288 |
| 83 | negative regulation of catecholamine secretion (GO:0033604) | 3.30129223 |
| 84 | synaptic transmission, glutamatergic (GO:0035249) | 3.29993680 |
| 85 | postsynaptic membrane organization (GO:0001941) | 3.29845369 |
| 86 | cell wall macromolecule metabolic process (GO:0044036) | 3.26408114 |
| 87 | cell wall macromolecule catabolic process (GO:0016998) | 3.26408114 |
| 88 | regulation of protein kinase A signaling (GO:0010738) | 3.26377897 |
| 89 | detection of calcium ion (GO:0005513) | 3.25831375 |
| 90 | ubiquinone biosynthetic process (GO:0006744) | 3.25618059 |
| 91 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.25215482 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24635338 |
| 93 | muscle contraction (GO:0006936) | 3.24468928 |
| 94 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.23422752 |
| 95 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.23422752 |
| 96 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.22687484 |
| 97 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.22415378 |
| 98 | response to muscle activity (GO:0014850) | 3.20627952 |
| 99 | response to inactivity (GO:0014854) | 3.20343260 |
| 100 | regulation of synapse structural plasticity (GO:0051823) | 3.20008923 |
| 101 | glucan catabolic process (GO:0009251) | 3.19921113 |
| 102 | tricarboxylic acid cycle (GO:0006099) | 3.18846762 |
| 103 | relaxation of smooth muscle (GO:0044557) | 3.18528194 |
| 104 | negative regulation of inclusion body assembly (GO:0090084) | 3.16595197 |
| 105 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.14610455 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 3.11681333 |
| 107 | activation of protein kinase A activity (GO:0034199) | 3.11548138 |
| 108 | negative regulation of heart contraction (GO:0045822) | 3.10844662 |
| 109 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.10594608 |
| 110 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.09959174 |
| 111 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08681269 |
| 112 | plasma membrane fusion (GO:0045026) | 3.05622815 |
| 113 | long-term synaptic potentiation (GO:0060291) | 3.04151192 |
| 114 | regulation of platelet activation (GO:0010543) | 3.03298857 |
| 115 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.02987722 |
| 116 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.02412236 |
| 117 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02311120 |
| 118 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.01415267 |
| 119 | protein complex biogenesis (GO:0070271) | 3.01133539 |
| 120 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.01007785 |
| 121 | regulation of neurotransmitter secretion (GO:0046928) | 3.00359794 |
| 122 | muscle system process (GO:0003012) | 2.99555819 |
| 123 | muscle fiber development (GO:0048747) | 2.99259534 |
| 124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.99132462 |
| 125 | regulation of postsynaptic membrane potential (GO:0060078) | 2.97682900 |
| 126 | protein localization to cilium (GO:0061512) | 2.96304206 |
| 127 | striatum development (GO:0021756) | 2.95807247 |
| 128 | behavioral response to cocaine (GO:0048148) | 2.95717816 |
| 129 | membrane depolarization (GO:0051899) | 2.95161613 |
| 130 | cellular polysaccharide catabolic process (GO:0044247) | 2.94316982 |
| 131 | neurotransmitter transport (GO:0006836) | 2.94298964 |
| 132 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93341836 |
| 133 | regulation of norepinephrine secretion (GO:0014061) | 2.93049412 |
| 134 | exploration behavior (GO:0035640) | 2.92385794 |
| 135 | heart process (GO:0003015) | 2.92241190 |
| 136 | heart contraction (GO:0060047) | 2.92241190 |
| 137 | negative regulation of cation channel activity (GO:2001258) | 2.91872867 |
| 138 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.91257658 |
| 139 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.90890135 |
| 140 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.90673533 |
| 141 | beta-amyloid metabolic process (GO:0050435) | 2.89585871 |
| 142 | negative regulation of platelet activation (GO:0010544) | 2.89273350 |
| 143 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.88903773 |
| 144 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.88596606 |
| 145 | regulation of coenzyme metabolic process (GO:0051196) | 2.87509219 |
| 146 | regulation of cofactor metabolic process (GO:0051193) | 2.87509219 |
| 147 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.86783100 |
| 148 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.86783100 |
| 149 | cardiac muscle contraction (GO:0060048) | 2.85613512 |
| 150 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84714663 |
| 151 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83069989 |
| 152 | cellular potassium ion homeostasis (GO:0030007) | 2.82830863 |
| 153 | neuromuscular synaptic transmission (GO:0007274) | 2.82221137 |
| 154 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.82205883 |
| 155 | cardiac muscle hypertrophy (GO:0003300) | 2.81657374 |
| 156 | cardiac myofibril assembly (GO:0055003) | 2.81580532 |
| 157 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80800123 |
| 158 | negative regulation of blood circulation (GO:1903523) | 2.80508148 |
| 159 | multicellular organism reproduction (GO:0032504) | 2.80392000 |
| 160 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80123401 |
| 161 | startle response (GO:0001964) | 2.79161359 |
| 162 | cerebellar granule cell differentiation (GO:0021707) | 2.78833927 |
| 163 | dopamine transport (GO:0015872) | 2.78300147 |
| 164 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.78210657 |
| 165 | positive regulation of membrane potential (GO:0045838) | 2.77449456 |
| 166 | regulation of synaptic plasticity (GO:0048167) | 2.77387810 |
| 167 | sperm-egg recognition (GO:0035036) | 2.77303098 |
| 168 | regulation of neurotransmitter transport (GO:0051588) | 2.77293373 |
| 169 | calcium ion import (GO:0070509) | 2.77219901 |
| 170 | gamma-aminobutyric acid transport (GO:0015812) | 2.76959647 |
| 171 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.76775640 |
| 172 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.75190327 |
| 173 | regulation of lipoprotein metabolic process (GO:0050746) | 2.74966655 |
| 174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.74519865 |
| 175 | microtubule depolymerization (GO:0007019) | 2.74483266 |
| 176 | regulation of membrane repolarization (GO:0060306) | 2.73619392 |
| 177 | ubiquinone metabolic process (GO:0006743) | 2.72083662 |
| 178 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.69991774 |
| 179 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.68495324 |
| 180 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.67696608 |
| 181 | female mating behavior (GO:0060180) | 2.67657777 |
| 182 | mitochondrial calcium ion transport (GO:0006851) | 2.67314634 |
| 183 | striated muscle hypertrophy (GO:0014897) | 2.66961849 |
| 184 | glycogen biosynthetic process (GO:0005978) | 2.64937144 |
| 185 | glucan biosynthetic process (GO:0009250) | 2.64937144 |
| 186 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.63343340 |
| 187 | regulation of actin filament-based movement (GO:1903115) | 2.63106453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.22133616 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44119294 |
| 3 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.79131052 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.78364064 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.69822329 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67518992 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.60069977 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.57571467 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50529708 |
| 10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.50507332 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40805777 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.33632246 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32658529 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.17105218 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16147565 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12762851 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.12387784 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.11278567 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.10094990 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.10007426 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08645573 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02033959 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98602552 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97594405 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95482712 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94801321 |
| 27 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91747669 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.91630900 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.91630900 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89874854 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86843094 |
| 32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86741797 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82608584 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.82422413 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82035378 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79166060 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78394548 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.77379736 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.72325276 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67453385 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64083770 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63909668 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60835283 |
| 44 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57280074 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55369237 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54460731 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.53369123 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51795906 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50386588 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49742008 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43476296 |
| 52 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41134930 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39947192 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39779267 |
| 55 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39391219 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36445031 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35627007 |
| 58 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.33826184 |
| 59 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.33461392 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33028836 |
| 61 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.30049887 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.29750821 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29308151 |
| 64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28287398 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27716140 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27339375 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26449538 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25934082 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24185814 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23923818 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23543912 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23497746 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22182448 |
| 74 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.22056958 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.20512440 |
| 76 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20426324 |
| 77 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.18322906 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18139826 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18139826 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17330758 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17131450 |
| 82 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.17067719 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17064910 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17064910 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16398481 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15538964 |
| 87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14949276 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14655832 |
| 89 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.14424212 |
| 90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14106607 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13972231 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12831899 |
| 93 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12553073 |
| 94 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.11176936 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10519494 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10476656 |
| 97 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10452575 |
| 98 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08774095 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08105772 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07075279 |
| 101 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06926258 |
| 102 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06844725 |
| 103 | NFYB_21822215_ChIP-Seq_K562_Human | 1.06528360 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06249837 |
| 105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06105418 |
| 106 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05728567 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05596138 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04460684 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02605795 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.02048465 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01798677 |
| 112 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01622320 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01622320 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01116600 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00760141 |
| 116 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00663552 |
| 117 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00434324 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99669372 |
| 119 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.99388560 |
| 120 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99047436 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98613061 |
| 122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98373484 |
| 123 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98290063 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98163454 |
| 125 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97132268 |
| 126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96926052 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96801051 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96795452 |
| 129 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.95887629 |
| 130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95371503 |
| 131 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95324922 |
| 132 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94709272 |
| 133 | * AR_19668381_ChIP-Seq_PC3_Human | 0.94464884 |
| 134 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.94458969 |
| 135 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94334613 |
| 136 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94244506 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93917237 |
| 138 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93500410 |
| 139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92979294 |
| 140 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92871083 |
| 141 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92016334 |
| 142 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91862327 |
| 143 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91717023 |
| 144 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.91630264 |
| 145 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91384068 |
| 146 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91308704 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91204761 |
| 148 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89975098 |
| 149 | NFYA_21822215_ChIP-Seq_K562_Human | 0.89686716 |
| 150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87977044 |
| 151 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85394502 |
| 152 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.84540056 |
| 153 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83924299 |
| 154 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83924299 |
| 155 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83812768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.57075396 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.38789514 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.18395479 |
| 4 | MP0005410_abnormal_fertilization | 3.56483046 |
| 5 | MP0003646_muscle_fatigue | 3.42763309 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.30936487 |
| 7 | MP0000751_myopathy | 3.08828626 |
| 8 | MP0009046_muscle_twitch | 3.06918929 |
| 9 | MP0004270_analgesia | 2.99143691 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.97519538 |
| 11 | MP0009745_abnormal_behavioral_response | 2.91957134 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.90825379 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.74424438 |
| 14 | MP0002064_seizures | 2.70657043 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.65056303 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.40069188 |
| 17 | MP0002822_catalepsy | 2.36850480 |
| 18 | MP0002272_abnormal_nervous_system | 2.31984285 |
| 19 | MP0002736_abnormal_nociception_after | 2.27541583 |
| 20 | MP0001984_abnormal_olfaction | 2.23553476 |
| 21 | MP0000749_muscle_degeneration | 2.18799306 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.18690644 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.08118378 |
| 24 | MP0001486_abnormal_startle_reflex | 2.01361624 |
| 25 | MP0004233_abnormal_muscle_weight | 1.93972158 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.93970676 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.92431659 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.89804127 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.85395121 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.82368522 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.78323171 |
| 32 | MP0004510_myositis | 1.76984878 |
| 33 | MP0008004_abnormal_stomach_pH | 1.74225208 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.68462923 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.59449876 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.59048467 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.56627311 |
| 38 | MP0001529_abnormal_vocalization | 1.56542561 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.55795441 |
| 40 | MP0004924_abnormal_behavior | 1.49842953 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.49842953 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.49311004 |
| 43 | MP0003879_abnormal_hair_cell | 1.49119952 |
| 44 | MP0000230_abnormal_systemic_arterial | 1.47811693 |
| 45 | MP0008569_lethality_at_weaning | 1.46777701 |
| 46 | MP0004484_altered_response_of | 1.45238651 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.43918936 |
| 48 | MP0003698_abnormal_male_reproductive | 1.42359896 |
| 49 | MP0004130_abnormal_muscle_cell | 1.41978820 |
| 50 | MP0001970_abnormal_pain_threshold | 1.39903674 |
| 51 | MP0002106_abnormal_muscle_physiology | 1.39666441 |
| 52 | MP0000747_muscle_weakness | 1.39524660 |
| 53 | MP0004142_abnormal_muscle_tone | 1.35997623 |
| 54 | MP0005083_abnormal_biliary_tract | 1.34416961 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.33914237 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.31938567 |
| 57 | MP0009697_abnormal_copulation | 1.31826898 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.31045457 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.30653300 |
| 60 | MP0005385_cardiovascular_system_phenoty | 1.26451974 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.26451974 |
| 62 | MP0002269_muscular_atrophy | 1.23469708 |
| 63 | MP0003329_amyloid_beta_deposits | 1.22002892 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.21207231 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.20842157 |
| 66 | MP0003633_abnormal_nervous_system | 1.19346706 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.18676745 |
| 68 | MP0002184_abnormal_innervation | 1.18472761 |
| 69 | MP0003186_abnormal_redox_activity | 1.17785997 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.17765084 |
| 71 | MP0004085_abnormal_heartbeat | 1.17699996 |
| 72 | MP0005369_muscle_phenotype | 1.17568925 |
| 73 | MP0003787_abnormal_imprinting | 1.17000544 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.16186586 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.16071327 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.16016707 |
| 77 | MP0004087_abnormal_muscle_fiber | 1.15561006 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.15213000 |
| 79 | MP0003718_maternal_effect | 1.13387066 |
| 80 | MP0002332_abnormal_exercise_endurance | 1.13328140 |
| 81 | MP0003122_maternal_imprinting | 1.11757676 |
| 82 | MP0004147_increased_porphyrin_level | 1.11329862 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 1.10357767 |
| 84 | MP0003638_abnormal_response/metabolism_ | 1.09745668 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 1.09475513 |
| 86 | MP0001661_extended_life_span | 1.06011586 |
| 87 | MP0001905_abnormal_dopamine_level | 1.05944503 |
| 88 | MP0002882_abnormal_neuron_morphology | 1.04025019 |
| 89 | MP0003011_delayed_dark_adaptation | 1.02115483 |
| 90 | MP0000778_abnormal_nervous_system | 1.01794323 |
| 91 | MP0003137_abnormal_impulse_conducting | 1.00560616 |
| 92 | MP0005451_abnormal_body_composition | 1.00537993 |
| 93 | MP0002972_abnormal_cardiac_muscle | 1.00277564 |
| 94 | MP0005330_cardiomyopathy | 0.99758328 |
| 95 | MP0000343_altered_response_to | 0.98054322 |
| 96 | MP0000955_abnormal_spinal_cord | 0.97684205 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.97411054 |
| 98 | MP0004043_abnormal_pH_regulation | 0.95295376 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.94969582 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.91885325 |
| 101 | MP0005499_abnormal_olfactory_system | 0.90629902 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.90629902 |
| 103 | MP0001929_abnormal_gametogenesis | 0.90130798 |
| 104 | MP0004133_heterotaxia | 0.89026205 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.88475892 |
| 106 | MP0003631_nervous_system_phenotype | 0.88120764 |
| 107 | MP0002163_abnormal_gland_morphology | 0.87387001 |
| 108 | MP0003828_pulmonary_edema | 0.85424893 |
| 109 | MP0005266_abnormal_metabolism | 0.85320557 |
| 110 | MP0005535_abnormal_body_temperature | 0.84671093 |
| 111 | MP0000733_abnormal_muscle_development | 0.84451327 |
| 112 | MP0002229_neurodegeneration | 0.83866380 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.83056782 |
| 114 | MP0009379_abnormal_foot_pigmentation | 0.81079708 |
| 115 | MP0005187_abnormal_penis_morphology | 0.81048151 |
| 116 | MP0001879_abnormal_lymphatic_vessel | 0.80412417 |
| 117 | MP0003123_paternal_imprinting | 0.80352256 |
| 118 | MP0008872_abnormal_physiological_respon | 0.80210792 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.77540374 |
| 120 | MP0001188_hyperpigmentation | 0.77213868 |
| 121 | MP0002152_abnormal_brain_morphology | 0.76161399 |
| 122 | MP0004858_abnormal_nervous_system | 0.75373720 |
| 123 | MP0000750_abnormal_muscle_regeneration | 0.75233586 |
| 124 | MP0008961_abnormal_basal_metabolism | 0.74523600 |
| 125 | MP0008874_decreased_physiological_sensi | 0.74303729 |
| 126 | MP0008775_abnormal_heart_ventricle | 0.72516658 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.70435498 |
| 128 | MP0002161_abnormal_fertility/fecundity | 0.68827569 |
| 129 | MP0010630_abnormal_cardiac_muscle | 0.68809175 |
| 130 | MP0002069_abnormal_eating/drinking_beha | 0.67585288 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.65666318 |
| 132 | MP0006292_abnormal_olfactory_placode | 0.65575611 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.64983121 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.64413193 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.64101083 |
| 136 | MP0006138_congestive_heart_failure | 0.64100137 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.63599192 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.62896990 |
| 139 | MP0002638_abnormal_pupillary_reflex | 0.61063050 |
| 140 | MP0002752_abnormal_somatic_nervous | 0.60652702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.49272905 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.89092108 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 5.89092108 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.33016058 |
| 5 | Increased mean platelet volume (HP:0011877) | 5.24828994 |
| 6 | Prolonged bleeding time (HP:0003010) | 5.09759494 |
| 7 | Exercise-induced myalgia (HP:0003738) | 5.03649979 |
| 8 | Menorrhagia (HP:0000132) | 4.88574615 |
| 9 | Abnormal platelet volume (HP:0011876) | 4.68762119 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.53475670 |
| 11 | Atonic seizures (HP:0010819) | 4.45086761 |
| 12 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.35166264 |
| 13 | Petechiae (HP:0000967) | 4.34517576 |
| 14 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.15525351 |
| 15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.15525351 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.14254387 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.07415755 |
| 18 | Focal seizures (HP:0007359) | 4.05068611 |
| 19 | Abnormal ciliary motility (HP:0012262) | 3.98928062 |
| 20 | Calf muscle hypertrophy (HP:0008981) | 3.96367852 |
| 21 | Febrile seizures (HP:0002373) | 3.94511634 |
| 22 | Purpura (HP:0000979) | 3.83273047 |
| 23 | Hyperventilation (HP:0002883) | 3.75169427 |
| 24 | Myokymia (HP:0002411) | 3.74084370 |
| 25 | Absence seizures (HP:0002121) | 3.69366074 |
| 26 | Visual hallucinations (HP:0002367) | 3.43011464 |
| 27 | Rhinitis (HP:0012384) | 3.36569513 |
| 28 | Dialeptic seizures (HP:0011146) | 3.26465915 |
| 29 | Broad-based gait (HP:0002136) | 3.12040929 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.09196009 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 3.08903605 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.91861452 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.91670148 |
| 34 | Sudden death (HP:0001699) | 2.87884537 |
| 35 | Myoglobinuria (HP:0002913) | 2.87541990 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 2.83331366 |
| 37 | Subaortic stenosis (HP:0001682) | 2.80223578 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.80223578 |
| 39 | Dysmetric saccades (HP:0000641) | 2.79834271 |
| 40 | Epistaxis (HP:0000421) | 2.76568273 |
| 41 | Neck muscle weakness (HP:0000467) | 2.70844721 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 2.69878955 |
| 43 | Absent phalangeal crease (HP:0006109) | 2.69680681 |
| 44 | Ulnar deviation of the wrist (HP:0003049) | 2.69345361 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.69343927 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.68625980 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.67604410 |
| 48 | Infertility (HP:0000789) | 2.67272256 |
| 49 | Paralysis (HP:0003470) | 2.67037955 |
| 50 | Calcaneovalgus deformity (HP:0001848) | 2.66447260 |
| 51 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.65741095 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.64804074 |
| 53 | Hyporeflexia of lower limbs (HP:0002600) | 2.63689557 |
| 54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62960379 |
| 55 | Chronic bronchitis (HP:0004469) | 2.61326393 |
| 56 | Areflexia of lower limbs (HP:0002522) | 2.55522660 |
| 57 | Exercise intolerance (HP:0003546) | 2.54360414 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.50193036 |
| 59 | Abnormality of alanine metabolism (HP:0010916) | 2.50193036 |
| 60 | Hyperalaninemia (HP:0003348) | 2.50193036 |
| 61 | Abnormal platelet function (HP:0011869) | 2.46906957 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.46906957 |
| 63 | Pheochromocytoma (HP:0002666) | 2.46107838 |
| 64 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46048913 |
| 65 | Myotonia (HP:0002486) | 2.45667709 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.44652310 |
| 67 | Dysdiadochokinesis (HP:0002075) | 2.43767257 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.39548381 |
| 69 | Poor eye contact (HP:0000817) | 2.37725089 |
| 70 | Frequent falls (HP:0002359) | 2.37597887 |
| 71 | Nemaline bodies (HP:0003798) | 2.32655913 |
| 72 | Abnormal pupillary function (HP:0007686) | 2.31566917 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.30097841 |
| 74 | Weak cry (HP:0001612) | 2.29624422 |
| 75 | Gait imbalance (HP:0002141) | 2.29330736 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.28235327 |
| 77 | Difficulty running (HP:0009046) | 2.27239102 |
| 78 | Hepatic necrosis (HP:0002605) | 2.25946563 |
| 79 | Progressive inability to walk (HP:0002505) | 2.25182599 |
| 80 | Muscle stiffness (HP:0003552) | 2.24859765 |
| 81 | Deformed tarsal bones (HP:0008119) | 2.24703722 |
| 82 | Central scotoma (HP:0000603) | 2.24113991 |
| 83 | Muscle fiber splitting (HP:0003555) | 2.23806972 |
| 84 | Bundle branch block (HP:0011710) | 2.23617156 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.22910340 |
| 86 | Inability to walk (HP:0002540) | 2.21519506 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 2.21247591 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.16434564 |
| 89 | Dyschromatopsia (HP:0007641) | 2.16141555 |
| 90 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.12028487 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.11054780 |
| 92 | Left ventricular hypertrophy (HP:0001712) | 2.10399596 |
| 93 | Anxiety (HP:0000739) | 2.09025955 |
| 94 | Amblyopia (HP:0000646) | 2.08333821 |
| 95 | EMG: neuropathic changes (HP:0003445) | 2.06941758 |
| 96 | Impaired social interactions (HP:0000735) | 2.05969856 |
| 97 | Abnormal social behavior (HP:0012433) | 2.05969856 |
| 98 | Shoulder girdle muscle weakness (HP:0003547) | 2.05751769 |
| 99 | Hyperthyroidism (HP:0000836) | 2.03848748 |
| 100 | Abnormal finger flexion creases (HP:0006143) | 2.03682958 |
| 101 | Acute encephalopathy (HP:0006846) | 2.02703402 |
| 102 | Depression (HP:0000716) | 2.02313949 |
| 103 | Oligomenorrhea (HP:0000876) | 2.02023633 |
| 104 | Progressive muscle weakness (HP:0003323) | 2.01233730 |
| 105 | Type 1 muscle fiber predominance (HP:0003803) | 2.01166602 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.00569229 |
| 107 | Truncal ataxia (HP:0002078) | 1.99203132 |
| 108 | Fetal akinesia sequence (HP:0001989) | 1.98825943 |
| 109 | Abnormal eating behavior (HP:0100738) | 1.97936776 |
| 110 | Cerebral edema (HP:0002181) | 1.97839099 |
| 111 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97767145 |
| 112 | Atrial fibrillation (HP:0005110) | 1.97287320 |
| 113 | Dilated cardiomyopathy (HP:0001644) | 1.97222981 |
| 114 | Poikilocytosis (HP:0004447) | 1.97080295 |
| 115 | Cholecystitis (HP:0001082) | 1.96784767 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 1.96784767 |
| 117 | Urinary urgency (HP:0000012) | 1.96683121 |
| 118 | Syncope (HP:0001279) | 1.95698273 |
| 119 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95521089 |
| 120 | Optic disc pallor (HP:0000543) | 1.95399167 |
| 121 | Abnormality of lateral ventricle (HP:0030047) | 1.94044868 |
| 122 | Generalized muscle weakness (HP:0003324) | 1.93861062 |
| 123 | Ankle clonus (HP:0011448) | 1.91152209 |
| 124 | Dysmetria (HP:0001310) | 1.90752716 |
| 125 | Mitochondrial inheritance (HP:0001427) | 1.90303877 |
| 126 | Ventricular fibrillation (HP:0001663) | 1.89370792 |
| 127 | Primary atrial arrhythmia (HP:0001692) | 1.88598401 |
| 128 | Distal arthrogryposis (HP:0005684) | 1.87789638 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85280361 |
| 130 | Impaired vibratory sensation (HP:0002495) | 1.83742927 |
| 131 | Hypoglycemic coma (HP:0001325) | 1.83268449 |
| 132 | Hemiparesis (HP:0001269) | 1.82573958 |
| 133 | Gingival bleeding (HP:0000225) | 1.81631282 |
| 134 | Round ear (HP:0100830) | 1.80615488 |
| 135 | Postural instability (HP:0002172) | 1.79774276 |
| 136 | Prolonged QT interval (HP:0001657) | 1.79498567 |
| 137 | Nephronophthisis (HP:0000090) | 1.78065649 |
| 138 | Lower limb amyotrophy (HP:0007210) | 1.77825655 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.77734891 |
| 140 | Supraventricular tachycardia (HP:0004755) | 1.76964415 |
| 141 | Heart block (HP:0012722) | 1.76401888 |
| 142 | Hypoglycemic seizures (HP:0002173) | 1.76265444 |
| 143 | Rhabdomyolysis (HP:0003201) | 1.75996190 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.75555619 |
| 145 | Malignant hyperthermia (HP:0002047) | 1.75280012 |
| 146 | Abnormal EKG (HP:0003115) | 1.75176948 |
| 147 | Increased CSF lactate (HP:0002490) | 1.73907922 |
| 148 | Polyphagia (HP:0002591) | 1.73145924 |
| 149 | Hyperglycinemia (HP:0002154) | 1.72474657 |
| 150 | Hyperglycinuria (HP:0003108) | 1.71274002 |
| 151 | Rimmed vacuoles (HP:0003805) | 1.70334052 |
| 152 | Resting tremor (HP:0002322) | 1.70139616 |
| 153 | Myopathic facies (HP:0002058) | 1.70103095 |
| 154 | Renal Fanconi syndrome (HP:0001994) | 1.68636309 |
| 155 | Increased muscle lipid content (HP:0009058) | 1.68537459 |
| 156 | Conjunctival telangiectasia (HP:0000524) | 1.67125001 |
| 157 | Metaphyseal dysplasia (HP:0100255) | 1.67011428 |
| 158 | Lipoatrophy (HP:0100578) | 1.65045217 |
| 159 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.64405458 |
| 160 | Fatigable weakness (HP:0003473) | 1.63711833 |
| 161 | Abnormality of the neuromuscular junction (HP:0003398) | 1.63711833 |
| 162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.63646534 |
| 163 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.61857772 |
| 164 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.61857772 |
| 165 | Abnormal atrioventricular conduction (HP:0005150) | 1.59967873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.34725771 |
| 2 | PDK4 | 4.09139486 |
| 3 | PDK3 | 4.09139486 |
| 4 | EPHA4 | 3.82029831 |
| 5 | MST4 | 3.33567467 |
| 6 | NTRK3 | 3.11139170 |
| 7 | MAP3K4 | 2.70862328 |
| 8 | DAPK2 | 2.52508120 |
| 9 | PDK2 | 2.51004358 |
| 10 | MAP2K7 | 2.41837097 |
| 11 | EIF2AK1 | 2.38245885 |
| 12 | MAP3K12 | 2.30953658 |
| 13 | MAP4K2 | 2.25378609 |
| 14 | MAP3K9 | 2.23937851 |
| 15 | BMX | 2.19095727 |
| 16 | PHKG2 | 2.08243550 |
| 17 | PHKG1 | 2.08243550 |
| 18 | MAP2K4 | 2.04830399 |
| 19 | PIK3CG | 2.04644959 |
| 20 | OBSCN | 2.04341938 |
| 21 | CCNB1 | 2.02858139 |
| 22 | PRKD3 | 2.01764641 |
| 23 | CDK19 | 1.89893065 |
| 24 | ILK | 1.84906448 |
| 25 | DAPK1 | 1.71627767 |
| 26 | ARAF | 1.67718383 |
| 27 | MINK1 | 1.63289134 |
| 28 | RIPK4 | 1.60514209 |
| 29 | NME1 | 1.60145874 |
| 30 | PLK2 | 1.54967437 |
| 31 | PTK2B | 1.43612131 |
| 32 | PINK1 | 1.41227446 |
| 33 | PNCK | 1.40389489 |
| 34 | PAK6 | 1.35956543 |
| 35 | TTN | 1.33584367 |
| 36 | TRIM28 | 1.31940906 |
| 37 | AKT3 | 1.31317775 |
| 38 | TIE1 | 1.27049293 |
| 39 | KSR2 | 1.26353778 |
| 40 | MARK1 | 1.25632372 |
| 41 | NTRK2 | 1.25306804 |
| 42 | STK38 | 1.19062584 |
| 43 | BCKDK | 1.18424361 |
| 44 | PRPF4B | 1.13184525 |
| 45 | NEK1 | 1.12235773 |
| 46 | CAMKK1 | 1.09208129 |
| 47 | DYRK2 | 1.05037316 |
| 48 | CAMK2A | 1.04500511 |
| 49 | OXSR1 | 1.03312047 |
| 50 | LIMK1 | 1.03180320 |
| 51 | KSR1 | 1.02135632 |
| 52 | CAMKK2 | 1.02019382 |
| 53 | PKN1 | 1.00096358 |
| 54 | GRK5 | 0.99525220 |
| 55 | PRKCG | 0.98874166 |
| 56 | CDK5 | 0.95701489 |
| 57 | LMTK2 | 0.95566686 |
| 58 | MUSK | 0.93253018 |
| 59 | ADRBK2 | 0.91418939 |
| 60 | BRAF | 0.89191275 |
| 61 | CSNK1G3 | 0.87009531 |
| 62 | STK16 | 0.83677431 |
| 63 | SGK2 | 0.81646830 |
| 64 | STK3 | 0.81623909 |
| 65 | TNIK | 0.80861562 |
| 66 | CSNK1G1 | 0.78868703 |
| 67 | SGK223 | 0.78812443 |
| 68 | SGK494 | 0.78812443 |
| 69 | TEC | 0.78647774 |
| 70 | MAPKAPK3 | 0.78610168 |
| 71 | PDK1 | 0.76731977 |
| 72 | MYLK | 0.75174140 |
| 73 | MAPK13 | 0.74053126 |
| 74 | PAK1 | 0.73647306 |
| 75 | PIM2 | 0.73383974 |
| 76 | ICK | 0.72357224 |
| 77 | MAPK12 | 0.71262556 |
| 78 | STK39 | 0.70796025 |
| 79 | WNK4 | 0.70655573 |
| 80 | CAMK2B | 0.70378119 |
| 81 | GRK7 | 0.68590845 |
| 82 | ZAK | 0.67360807 |
| 83 | NTRK1 | 0.66590979 |
| 84 | RAF1 | 0.66296900 |
| 85 | ERBB3 | 0.65925787 |
| 86 | TESK1 | 0.65865719 |
| 87 | PDPK1 | 0.65779199 |
| 88 | PRKG1 | 0.65636599 |
| 89 | CAMK2D | 0.65621178 |
| 90 | FES | 0.65514137 |
| 91 | CSNK1G2 | 0.65325966 |
| 92 | NLK | 0.65222929 |
| 93 | CAMK1 | 0.63839015 |
| 94 | BMPR2 | 0.62064824 |
| 95 | BTK | 0.61929663 |
| 96 | MARK3 | 0.61752683 |
| 97 | TNK2 | 0.60400271 |
| 98 | MAP2K3 | 0.57908463 |
| 99 | SGK1 | 0.57886032 |
| 100 | PLK3 | 0.57593357 |
| 101 | DAPK3 | 0.57068895 |
| 102 | WNK1 | 0.56711563 |
| 103 | CAMK2G | 0.56697995 |
| 104 | PIK3CA | 0.56539522 |
| 105 | CDK18 | 0.54692365 |
| 106 | SGK3 | 0.54282360 |
| 107 | BRSK2 | 0.54274558 |
| 108 | STK11 | 0.53627571 |
| 109 | TYRO3 | 0.53014088 |
| 110 | MAP3K7 | 0.52611435 |
| 111 | MAP3K13 | 0.51968355 |
| 112 | VRK1 | 0.51235632 |
| 113 | PAK3 | 0.50553581 |
| 114 | CDK15 | 0.50217568 |
| 115 | SIK2 | 0.50123441 |
| 116 | EPHB2 | 0.49459001 |
| 117 | CDK14 | 0.48202169 |
| 118 | SRPK1 | 0.47243076 |
| 119 | PRKCE | 0.45613650 |
| 120 | SIK3 | 0.45164059 |
| 121 | BMPR1B | 0.44616642 |
| 122 | MAPK7 | 0.43949293 |
| 123 | BUB1 | 0.43399074 |
| 124 | MAP2K6 | 0.41680185 |
| 125 | ROCK1 | 0.41645943 |
| 126 | MAP3K1 | 0.40942306 |
| 127 | GRK1 | 0.40837681 |
| 128 | TAOK1 | 0.40670433 |
| 129 | AKT2 | 0.40520322 |
| 130 | CDK11A | 0.40139307 |
| 131 | RPS6KA3 | 0.39282035 |
| 132 | MAP2K1 | 0.39188201 |
| 133 | PRKACG | 0.38705051 |
| 134 | PBK | 0.38614529 |
| 135 | IRAK1 | 0.38323786 |
| 136 | TLK1 | 0.37784967 |
| 137 | PRKACA | 0.36891569 |
| 138 | DMPK | 0.36846801 |
| 139 | CAMK4 | 0.35489207 |
| 140 | STK24 | 0.34972620 |
| 141 | VRK2 | 0.34628464 |
| 142 | TSSK6 | 0.33330080 |
| 143 | ROCK2 | 0.32903813 |
| 144 | FER | 0.32298212 |
| 145 | PRKCH | 0.31796496 |
| 146 | CDK8 | 0.31586360 |
| 147 | ADRBK1 | 0.31345317 |
| 148 | WNK3 | 0.31140775 |
| 149 | PRKD1 | 0.29090465 |
| 150 | DYRK3 | 0.28961042 |
| 151 | ERBB2 | 0.28358159 |
| 152 | CSNK1D | 0.27869784 |
| 153 | INSRR | 0.26952601 |
| 154 | CSNK1A1 | 0.26575389 |
| 155 | BRSK1 | 0.26535780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.52431765 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.22591877 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.89142670 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.70077421 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 2.45831339 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.42872205 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.42581658 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39650076 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39348438 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38001524 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37245468 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.36846943 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.36331405 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.29731028 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26798777 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.25252232 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.19203415 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.11162236 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.98847589 |
| 20 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.97713928 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.96250676 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.86751851 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.86273485 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.82732825 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.82062825 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77486682 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76303521 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75736932 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72081897 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71950224 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68398544 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67366644 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.66556187 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64709911 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.50030514 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47835487 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.43039950 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39268408 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39108097 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38384882 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33527845 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.33257185 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31758887 |
| 44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.31358604 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29971862 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.28775057 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.28167779 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.25516171 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24826420 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.22369725 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21166747 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 1.20540751 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20365666 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17835894 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.15940135 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14163450 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13980853 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05172763 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04834018 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04219297 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.99254746 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98964487 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.97598059 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.97333052 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96595003 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95916908 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90748307 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88593389 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87352929 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87268889 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86216688 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85965998 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.84231189 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83273414 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82515373 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81824504 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.81815422 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81774444 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81546636 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78596168 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76440395 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74092635 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72484047 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72340888 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72171234 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69731097 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69473896 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69232997 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68221105 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67790084 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.66744116 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.65507970 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64944121 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64703769 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64176815 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63795756 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61944811 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60814364 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60780873 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59730678 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59430898 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58826978 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58411062 |
| 104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57865005 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57174198 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53113867 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53007705 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.50419222 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49734399 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.49679349 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45415241 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45146944 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44870243 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44676994 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43416971 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43128739 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40109548 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39959497 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39766286 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39265101 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38388536 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37840638 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36875995 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36593033 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.33679787 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32559589 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32228288 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31292997 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30790476 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30683817 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30050419 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29313294 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26840207 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24279086 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23949292 |
| 136 | Alcoholism_Homo sapiens_hsa05034 | 0.23862964 |
| 137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23632797 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23532022 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22575026 |
| 140 | Phagosome_Homo sapiens_hsa04145 | 0.22388597 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.22106089 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.20493022 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19451178 |

